http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102197132-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102197132-B |
| titleOfInvention | Biocide |
| abstract | The present invention relates to following endolysin variant, does described variant comprise the peptide section (peptide with film or LPS destruction activity merged? stretch) endolysin.And, the present invention relates to the nucleic acid molecule of the endolysin variant of described modification of encoding, comprise the carrier of described nucleic acid molecule and comprise the host cell of described nucleic acid molecule or described carrier.In addition, the present invention relates to the method for generation of described endolysin variant.In addition, the endolysin variant that the present invention relates to described modification as medicine, especially for treatment or prevention gram-negative bacterial infections, as diagnostic means, sterilizing agent or the purposes as cosmetically material.The invention still further relates to and remove or reduce or prevent the gram negative bacterium on the surface in food or food processing device, food processing plant, the surface contacted with food, medical facilities, hospital and operation from polluting.In addition, the present invention relates to described endolysin variant as the purposes of diagnostic means in medical science, food or feed or environment diagnosis.Finally, the present invention relates to the pharmaceutical composition of the endolysin variant comprising described modification. |
| priorityDate | 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 296.